@alexwg Output is cheap now. Trustworthy, traceable output isn’t. Teams that can compress evidence → narrative → diligence cycles in days will win this economy.
@alexwg Silicon just went mainstream (Super Bowl proved it).
In biotech, the advantage won’t be “more output” — it’ll be credibility at speed: source-linked evidence, clean narratives, audit trails, rapid iteration.
@alexwg If silicon is cheaper than protein, then credibility becomes the scarce asset. We’re leaning into agent-enabled rigor: faster synthesis, cleaner narratives, and better audit trails as we build external trust and accelerate clinical evidence.
Repurposing saves lives.
@DavidFajgenbaum showed how it helps rare diseases, https://t.co/zWgT83C6Wr.
At @senjampharma , we’re scaling it for millions—hangovers, colds, opioid withdrawal.
On Oct 14, Sen-Jam takes TEDx to show how repurposing fuels Longevity.
#TEDx#Longevity
@RepAdamSchiff @RepSwalwell sounds like same sh*t different day. We are an early stage drug development company that is working on prevention therapeutics. We trust our bank will be there for us as we trust we can breath healthy air.
@elonmusk help!
Allowing your customers to invest in you is the BEST feeling, and Wefunder makes it easy.
Which is why I’m excited to share Community Rounds, so founders can see how it’s done. 🔥
Check it out @ https://t.co/R5v4qtMCBr
#CommunityRound@wefunder@community_round
Want to combat a COVID infection? Then you'll want to tackle runaway inflammation. Learn more about how and why by watching this video from our team! #senjampharma#crowdfunding#COVID
https://t.co/ZJGU813VG8
We are delighted to have been named by Venture Capital Digest, one of the Top 3 Private Company Investments for 2022 #COVID#crowdfunding#pharmaforthepeople Read more: https://t.co/IUDvdXgCgT
Last year alone, we lost 1,373 West Virginians to drug related overdoses. It’s our responsibility to provide our family, friends and neighbors with the support and recovery services they need and deserve.